Literature DB >> 6630106

Persistence in serum and lungs of guinea pigs of erythromycin, gentamicin, chloramphenicol and rifampicin and their in-vitro activities against Legionella pneumophila.

D H Gibson, R B Fitzgeorge.   

Abstract

The penetration and persistence in the serum and lungs of guinea pigs after parenteral administration of erythromycin, gentamicin, chloramphenicol and rifampicin, and their in-vitro activities against Legionella pneumophila were investigated. The most active agent was rifampicin (MIC 0.0625 mg/l, MBC 0.125 mg/l) and effective levels of this drug were present in serum and lungs up to 10 h after injection. Erythromycin accumulated to very high levels in the lungs and had good bacteriostatic activity in vitro. Gentamicin was highly bactericidal in liquid culture but showed poor lung penetration on injection. Chloramphenicol, the least inhibitory of the four antibiotics, had an MIC of 1.0 mg/l. Active chloramphenicol was not detected in guinea pig serum and lungs following ip or im administration. The differences in the penetration and persistence of these drugs in the lungs of guinea pigs may explain the reported poor correlation between in-vitro and in-vivo activity against L. pneumophila. The results are useful for evaluating regimens for therapy of Legionnaires' disease in the aerosol infected guinea pig model.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6630106     DOI: 10.1093/jac/12.3.235

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  3 in total

1.  High-Throughput Intracellular Antimicrobial Susceptibility Testing of Legionella pneumophila.

Authors:  Lucius Chiaraviglio; James E Kirby
Journal:  Antimicrob Agents Chemother       Date:  2015-09-21       Impact factor: 5.191

2.  Antimicrobial therapy of experimental Legionella micdadei pneumonia in guinea pigs.

Authors:  A W Pasculle; J N Dowling; F N Frola; D A McDevitt; M A Levi
Journal:  Antimicrob Agents Chemother       Date:  1985-12       Impact factor: 5.191

3.  In vitro activity of ABT-773 against Legionella pneumophila, its pharmacokinetics in guinea pigs, and its use to treat guinea pigs with L. pneumophila pneumonia.

Authors:  P H Edelstein; F Higa; M A Edelstein
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.